Related Experiment Video
Updated: Jun 5, 2026

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells
Published on: February 27, 2020
Androgens activate mitogen-activated protein kinase via epidermal growth factor receptor/insulin-like growth factor 1
Mahsa Hamzeh1, Bernard Robaire
1Department of Pharmacology and Therapeutics, McGill University, McIntyre Medical Sciences Building, 3655 Promenade Sir-William-Osler, Montréal, Québec, Canada.
Abstract:
Androgens are the primary regulators of epididymal structure and functions. In the classical view of androgen action, binding of androgen to the intracellular androgen receptor (AR) produces the receptor-steroid complex that has high affinity for DNA response elements and regulates the transcription of target genes. In this study, we demonstrate that in epididymal cells, 5α-dihydrotestosterone (DHT) can cause an alternative and rapid response that is independent of AR-DNA interactions and is mediated by activation of signaling pathways through the AR. We examined changes in AKT and extracellular signal-regulated protein kinases (ERK1/2) activation at early time points after DHT supplementation in the mouse proximal caput epididymis-1 cell line. DHT had no significant effect on AKT activation at any time point. However, DHT activated the ERK pathway as early as at 1 min, the pathway remained activated at 10 min, but activation was not sustained at later time points. Interestingly, ERK activation was blocked by hydroxyflutamide (HF), indicating that early ERK activation was an AR-mediated response. DHT phosphorylates steroid receptor co-activator (SRC) kinase, and this activation was required for the ERK response. EGFR and IGF1R were downstream of SRC, and these two receptors together contributed to enhance ERK and cAMP response element-binding protein (CREB) phosphorylation. We postulate that this rapid action of androgen may ultimately act to modulate the transcription of genes regulated by AR in the nucleus. These results support the hypothesis that DHT can activate a pathway involving the sequential activation of MEK, ERK1/2, and CREB through the EGFR/IGF1R in an epididymal cell line.
Insights
5α-dihydrotestosterone (DHT) triggers rapid, non-genomic signaling in epididymal cells via androgen receptor (AR) activation. This pathway involves ERK activation, suggesting a novel mechanism for androgen action.
Area of Science:
- Reproductive Biology
- Molecular Endocrinology
- Cell Signaling
Background:
- Androgens are key regulators of epididymal function.
- Classical androgen action involves androgen receptor (AR) binding to DNA.
- Rapid, non-genomic signaling pathways are increasingly recognized.
Purpose of the Study:
- To investigate rapid, AR-mediated signaling pathways activated by 5α-dihydrotestosterone (DHT) in epididymal cells.
- To elucidate the role of ERK1/2 and AKT pathways in early DHT response.
- To identify downstream signaling molecules involved in DHT-induced epididymal cell activation.
Main Methods:
- Utilized the mouse proximal caput epididymis-1 cell line.
- Supplemented cells with DHT and measured protein activation (AKT, ERK1/2) at early time points.
- Investigated the role of hydroxyflutamide (HF), steroid receptor co-activator (SRC) kinase, EGFR, and IGF1R in the signaling cascade.
Main Results:
- DHT rapidly activated the ERK1/2 pathway within 1 minute, independent of AKT activation.
- Early ERK activation was AR-mediated and blocked by HF.
- DHT-induced SRC activation was essential for ERK response, with EGFR and IGF1R downstream, enhancing ERK and CREB phosphorylation.
Conclusions:
- DHT initiates a rapid, non-genomic signaling cascade in epididymal cells involving AR, SRC, EGFR/IGF1R, MEK, ERK1/2, and CREB.
- This rapid androgen action may modulate nuclear gene transcription.
- Identified a novel signaling pathway for androgen action in the epididymis.
Related Concept Videos
Mitogens and the Cell Cycle
Mitogens and the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways

